Showing results (141-150 of 181) with videos related to
Sort By:
Pageof 19
Plos Neglected Tropical Diseases|September 1, 2016
Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral LeishmaniasisParna Bhattacharya, Ranadhir Dey, Pradeep K Dagur, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 12, 2020
Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated <i>Leishmania</i> VaccineParna Bhattacharya, Ranadhir Dey, Ankit Saxena, et al.Infection and Immunity|July 15, 2015
Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in MiceParna Bhattacharya, Ranadhir Dey, Pradeep K Dagur, et al.Journal of the Peripheral Nervous System : JPNS|July 7, 2020
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic reviewRichard A Lewis, David R Cornblath, Hans-Peter Hartung, et al.Journal of the Peripheral Nervous System : JPNS|January 24, 2019
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra studyOrell Mielke, Vera Bril, David R Cornblath, et al.The Lancet. Neurology|November 11, 2017
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trialIvo N van Schaik, Vera Bril, Nan van Geloven, et al.Nature|September 16, 2021
UTX condensation underlies its tumour-suppressive activityBi Shi, Wei Li, Yansu Song, et al.Neurology(R) Neuroimmunology & Neuroinflammation|July 30, 2019
Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension studyIvo N van Schaik, Orell Mielke, Vera Bril, et al.Allergy|October 7, 2024
Long-term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open-label extension studyAvner Reshef, Connie Hsu, Constance H Katelaris, et al.Molecular & Cellular Proteomics : MCP|July 25, 2014
Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancerArpi Nazarian, Kevin Lawlor, San San Yi, et al.Pageof 19